These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 33629337)
1. Thromboembolic involvement and its possible pathogenesis in COVID-19 mortality: lesson from post-mortem reports. Dwiputra Hernugrahanto K; Novembri Utomo D; Hariman H; Budhiparama NC; Medika Hertanto D; Santoso D; Hogendoorn PCW Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1670-1679. PubMed ID: 33629337 [TBL] [Abstract][Full Text] [Related]
2. Higher prevalence of pulmonary macrothrombi in SARS-CoV-2 than in influenza A: autopsy results from 'Spanish flu' 1918/1919 in Switzerland to Coronavirus disease 2019. Burkhard-Koren NM; Haberecker M; Maccio U; Ruschitzka F; Schuepbach RA; Zinkernagel AS; Hardmeier T; Varga Z; Moch H J Pathol Clin Res; 2021 Mar; 7(2):135-143. PubMed ID: 33185036 [TBL] [Abstract][Full Text] [Related]
3. Increased number of pulmonary megakaryocytes in COVID-19 patients with diffuse alveolar damage: an autopsy study with clinical correlation and review of the literature. Valdivia-Mazeyra MF; Salas C; Nieves-Alonso JM; Martín-Fragueiro L; Bárcena C; Muñoz-Hernández P; Villar-Zarra K; Martín-López J; Ramasco-Rueda F; Fraga J; Jiménez-Heffernan JA Virchows Arch; 2021 Mar; 478(3):487-496. PubMed ID: 32915265 [TBL] [Abstract][Full Text] [Related]
4. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra). Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052 [TBL] [Abstract][Full Text] [Related]
5. The Impact of COVID-19 Disease on Platelets and Coagulation. Wool GD; Miller JL Pathobiology; 2021; 88(1):15-27. PubMed ID: 33049751 [TBL] [Abstract][Full Text] [Related]
6. Increase in venous thromboembolism in SARS-CoV-2 infected lung tissue: proteome analysis of lung parenchyma, isolated endothelium, and thrombi. Lopuhaä BV; Guzel C; van der Lee A; van den Bosch TPP; van Kemenade FJ; Huisman MV; Kruip MJHA; Luider TM; von der Thüsen JH Histopathology; 2024 May; 84(6):967-982. PubMed ID: 38253958 [TBL] [Abstract][Full Text] [Related]
7. Pathogenesis-directed therapy of 2019 novel coronavirus disease. Stratton CW; Tang YW; Lu H J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355 [TBL] [Abstract][Full Text] [Related]
8. Autopsy-Based Pulmonary and Vascular Pathology: Pulmonary Endotheliitis and Multi-Organ Involvement in COVID-19 Associated Deaths. Haberecker M; Schwarz EI; Steiger P; Frontzek K; Scholkmann F; Zeng X; Höller S; Moch H; Varga Z Respiration; 2022; 101(2):155-165. PubMed ID: 34525475 [TBL] [Abstract][Full Text] [Related]
9. Cause of death based on systematic post-mortem studies in patients with positive SARS-CoV-2 tissue PCR during the COVID-19 pandemic. Romanova ES; Vasilyev VV; Startseva G; Karev V; Rybakova MG; Platonov PG J Intern Med; 2021 Sep; 290(3):655-665. PubMed ID: 33872433 [TBL] [Abstract][Full Text] [Related]
10. Fatal pulmonary thromboembolism in asymptomatic COVID-19. Keane G; Dorman T Ir J Med Sci; 2022 Aug; 191(4):1777-1783. PubMed ID: 34482482 [TBL] [Abstract][Full Text] [Related]
11. Malignant Cerebral Ischemia in A COVID-19 Infected Patient: Case Review and Histopathological Findings. Patel SD; Kollar R; Troy P; Song X; Khaled M; Parra A; Pervez M J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105231. PubMed ID: 33066910 [TBL] [Abstract][Full Text] [Related]
12. Retrospective Post-mortem SARS-CoV-2 RT-PCR of Autopsies with COVID-19-Suggestive Pathology Supports the Absence of Lethal Community Spread in Basel, Switzerland, before February 2020. Haslbauer JD; Perrina V; Matter M; Dellas A; Mihatsch MJ; Tzankov A Pathobiology; 2021; 88(1):95-105. PubMed ID: 33161409 [TBL] [Abstract][Full Text] [Related]
13. Infection, atherothrombosis and thromboembolism beyond the COVID-19 disease: what similar in physiopathology and researches. Correale M; Tricarico L; Fortunato M; Dattilo G; Iacoviello M; Brunetti ND Aging Clin Exp Res; 2021 Feb; 33(2):273-278. PubMed ID: 33449336 [TBL] [Abstract][Full Text] [Related]
14. A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients. Roncati L; Ligabue G; Nasillo V; Lusenti B; Gennari W; Fabbiani L; Malagoli C; Gallo G; Giovanella S; Lupi M; Salviato T; Paolini A; Costantini M; Trenti T; Maiorana A Platelets; 2020 Nov; 31(8):1085-1089. PubMed ID: 32857624 [TBL] [Abstract][Full Text] [Related]
15. Multisystem Assessment of the Imaging Manifestations of Coagulopathy in Hospitalized Patients With Coronavirus Disease (COVID-19). O'Shea A; Parakh A; Hedgire S; Lee SI AJR Am J Roentgenol; 2021 Apr; 216(4):1088-1098. PubMed ID: 32755217 [No Abstract] [Full Text] [Related]
17. [COVID-19: Coagulopathy and thrombosis]. Tazi Mezalek Z Rev Med Interne; 2021 Feb; 42(2):93-100. PubMed ID: 33509669 [TBL] [Abstract][Full Text] [Related]
18. Endothelialitis plays a central role in the pathophysiology of severe COVID-19 and its cardiovascular complications. Vrints CJM; Krychtiuk KA; Van Craenenbroeck EM; Segers VF; Price S; Heidbuchel H Acta Cardiol; 2021 Apr; 76(2):109-124. PubMed ID: 33208052 [TBL] [Abstract][Full Text] [Related]